Showing results (31-40 of 174) with videos related to

Sort By:
Pageof 18
The Psychiatric Clinics of North America|March 1, 1986
The two-syndrome concept and neuroendocrinology of schizophreniaT J Crow, I N Ferrier, E C Johnstone
The British Journal of Psychiatry : the Journal of Mental Science|August 1, 1997
Service provision for people with schizophrenia. II. Role of the general practitionerF H Lang, E C Johnstone, G D Murray
Psychological Medicine|May 1, 1976
The coincidence of schizophrenia and Parkinsonism: some neurochemical implicationsT J Crow, E C Johnstone, H A McClelleand
The British Journal of Psychiatry : the Journal of Mental Science|April 1, 1984
Clinical effects of apomorphine in schizophreniaI N Ferrier, E C Johnstone, T J Crow
European Journal of Clinical Pharmacology|January 1, 1983
Reduced steady-state plasma concentrations of chlorpromazine and indomethacin in patients receiving cimetidineC A Howes, T Pullar, I Sourindhrin, et al.
Cancer Treatment Reports|November 1, 1979
Sorbent removal of adriamycin in vitro and in vivoJ F Winchester, A Rahman, W J Tilstone, et al.
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1979
Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotypeJ J Lima, D R Conti, A L Goldfarb, et al.
Journal of Psychopharmacology (Oxford, England)|February 3, 2012
L-dopa helps positive but not negative features of neuroleptic-insensitive chronic schizophreniaD G Owens, P E Harrison-Read, E C Johnstone
Pageof 18